N. R. Poulter, D. Prabhakaran, and M. Caulfield, Hypertension. Lancet, vol.386, pp.801-813, 2015.

B. Zhou, Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. NCD Risk Factor collaboration, Lancet, vol.389, pp.37-55, 2017.

F. G. Fowkes, Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis, Lancet, vol.382, pp.1329-1369, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00925590

G. Amah and B. I. Lévy, Particularités de l'hypertension artérielle du sujet noir-africain. Sang Thrombose Vaisseaux (STV), vol.19, pp.519-544, 2007.

, Integrative model of the common and sex-specific signatures and their main functional significance

D. Adeloye and C. Basquill, Estimating the prevalence and awareness rates of hypertension in Africa: a systematic analysis, PLoS One, vol.9, p.104300, 2014.

H. O. Bâ, Hypertension and Associated Factors in Rural and Urban Areas Mali: Data from the STEP 2013 Survey, Int J Hypertens, p.6959165, 2018.

W. K. Bosu, J. M. Aheto, E. Zucchelli, and S. T. Reilly, Determinants of systemic hypertension in older adults in Africa: a systematic review, BMC Cardiovasc. Disord, vol.19, p.173, 2019.

J. D. Spence and B. L. Rayner, Hypertension in Blacks Individualized Therapy Based on Renin/Aldosterone Phenotyping, Hypertension, vol.72, pp.263-69, 2018.

D. K. Arnett and S. A. Claas, Omics of Blood Pressure and Hypertension, Circ. Res, vol.122, pp.1409-1419, 2018.

I. Tzoulaki, A. Iliou, E. Mikros, and P. Elliott, An Overview of Metabolic Phenotyping in Blood Pressure Research, Curr. Hypertens. Rep, vol.20, p.78, 2018.

E. Holmes, Human metabolic phenotype diversity and its association with diet and blood pressure, Nature, vol.453, pp.396-400, 2008.

C. Menni, Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate, Hypertension, vol.66, pp.422-431, 2015.

L. Wang, Reconstruction and analysis of correlation networks based on GC-MS metabolomics data for young hypertensive men, Anal. Chim. Acta, vol.854, pp.95-105, 2015.

S. Dietrich, Identification of Serum Metabolites Associated With Incident Hypertension in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study, Hypertension, vol.68, pp.471-478, 2016.

K. Ameta, Essential hypertension: A filtered serum based metabolomics study, Sci. Rep, vol.7, p.2153, 2017.

H. Zhao, Identification of essential hypertension biomarkers in human urine by non-targeted metabolomics based on UPLC-Q-TOF/MS, Clin. Chim. Acta, vol.486, pp.192-198, 2018.

A. Hernández-aguilera, Plasma Energy-Balance Metabolites Discriminate Asymptomatic Patients with Peripheral Artery Disease, Mediators Inflamm, p.2760272, 2018.

H. Kulkarni, Plasma lipidomic profile signature of hypertension in Mexican American families: specific role of diacylglycerols, Hypertension, vol.62, pp.621-627, 2013.

C. Ke, X. Zhu, Y. Zhang, and Y. Shen, Metabolomic characterization of hypertension and dyslipidemia, Metabolomics, vol.14, p.117, 2018.

R. L. Loo, X. Zou, L. J. Appel, J. K. Nicholson, and E. Holmes, Characterization of metabolic responses to healthy diets and association with blood pressure: application to the Optimal Macronutrient Intake Trial for Heart Health (OmniHeart), a randomized controlled study, Am. J. Clin. Nutr, vol.107, pp.323-334, 2018.

L. Chen, Sodium Reduction, Metabolomic Profiling, and Cardiovascular Disease Risk in Untreated Black Hypertensives, Hypertension, vol.74, pp.194-200, 2019.

C. Hu, Application of plasma lipidomics in studying the response of patients with essential hypertension to antihypertensive drug therapy, Mol. Biosyst, vol.7, pp.3271-3280, 2011.

M. Kim, S. Jung, S. Y. Kim, S. H. Lee, and J. H. Lee, Prehypertension-associated elevation in circulating lysophosphatidlycholines, Lp-PLA2 activity, and oxidative stress, vol.9, p.96735, 2014.

T. P. Hiltunen, J. M. Rimpelä, R. P. Mohney, S. M. Stirdivant, and K. K. Kontula, Effects of four different antihypertensive drugs on plasma metabolomic profiles in patients with essential hypertension, PLoS One, vol.12, p.187729, 2017.

K. M. Colafella and K. M. Denton, Sex-specific differences in hypertension and associated cardiovascular disease, Nat. Rev. Nephrol, vol.14, pp.185-201, 2018.

S. Ahmed, R. Hu, J. Leete, and A. T. Layton, Understanding sex differences in long-term blood pressure regulation: insights from experimental studies and computational modeling, Am. J. Physiol. Heart Circ. Physiol, vol.316, pp.1113-1123, 2019.

E. Benjamin, Heart Disease and Stroke Statistics -2017 Update: A Report From the, American Heart Association. Circulation, vol.135, pp.146-603, 2017.

M. Tadic, C. Cuspidi, G. Grassi, and B. Ivanovic, Gender-specific therapeutic approach in arterial hypertension -Challenges ahead, Pharmacol. Res, vol.141, pp.181-188, 2019.

S. Leruez, A plasma metabolomic signature of the exfoliation syndrome involves amino acids, acyl-carnitines and polyamines, Invest. Ophthalmol. Vis. Sci, vol.59, pp.1025-1032, 2018.

S. Leruez, The metabolomic signature of glaucoma points to mitochondrial dysfunction, senescence and polyamines deficiency, Invest. Ophthalmol. Vis Sci, vol.59, pp.4355-4361, 2018.

L. Eriksson, Multi-and megavariate data analysis -Part I: Basic principles and applications, 2006.

J. Graessler, Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients, PLoS One, vol.4, p.6261, 2009.

P. Brites, H. Waterham, and R. Wanders, Functions and biosynthesis of plasmalogens in health and disease, Biochim. Biophys. Acta, vol.1636, pp.219-250, 2004.

A. Au, K. K. Cheng, L. K. Wei, and . Metabolomics, Lipidomics and Pharmacometabolomics of Human Hypertension, Adv. Exp. Med. Biol, vol.956, pp.599-613, 2017.

L. Romanowicz and E. Bankowski, Preeclampsia-associated alterations in sphingolipid composition of the umbilical cord artery, Clin. Biochem, vol.42, pp.1719-1743, 2009.

A. Dobierzewska, S. Soman, S. E. Illanes, and A. J. Morris, Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia, PLoS One, vol.12, p.175118, 2017.

A. M. Dorrance, D. Graham, R. C. Webb, R. Fraser, and A. Dominiczak, Increased membrane sphingomyelin and arachidonic acid in stroke-prone spontaneously hypertensive rats, Am. J. Hypertens, vol.14, pp.1149-53, 2001.

H. Hanamatsu, Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults, Nutr. Diabetes, vol.4, p.141, 2014.

A. Lana, Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtype-Specific Alterations, Proteomics Clin. Appl, vol.13, p.1800049, 2019.

F. Simko, Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension, Int. J. Mol. Sci, vol.19, 2018.

V. Achan, Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase, Arterioscler. Thromb. Vasc. Biol, vol.23, pp.1455-1464, 2003.

H. Veldink, Effects of chronic SDMA infusion on glomerular filtration rate, blood pressure, myocardial function and renal histology in C57BL6/J mice, Nephrol. Dial. Transplant, vol.28, pp.1434-1443, 2013.

S. M. Bode-böger, Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease, J. Am. Soc. Nephrol, vol.17, pp.1128-1162, 2006.

Y. L. Tain, C. N. Hsu, and . Dimethylarginines, Asymetric Dimethylarginine (ADMA) and Symetric Dimethylarginine (SDMA). Toxins (Basel, p.9, 2017.

S. Schlesinger, S. R. Sonntag, W. Lieb, and R. Maas, Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies, Int. J. Cardiol, vol.11, pp.109-113, 2016.

H. K. Zheng, Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline, Respir. Res, vol.19, p.94, 2018.

T. Eisenberg, Cardioprotection and lifespan extension by the natural polyamine spermidine, Nat. Med, vol.22, pp.1428-1438, 2016.

H. Toba, Oral L-histidine exerts antihypertensive effects via central histamine H3 receptors and decreases nitric oxide content in the rostral ventrolateral medulla in spontaneously hypertensive rats, Clin. Exp. Pharmacol. Physiol, vol.37, pp.62-70, 2010.

A. F. Sved, J. D. Fernstrom, and R. J. Wurtman, Tyrosine administration reduces blood pressure and enhances brain norepinephrine release in spontaneously hypertensive rats, Proc. Natl. Acad. Sci. USA, vol.76, pp.3511-3515, 1979.

B. M. Mitchell, A. M. Dorrance, and R. C. Webb, Phenylalanine improves dilation and blood pressure in GTP cyclohydrolase inhibition-induced hypertensive rats, J. Cardiovasc. Pharmacol, vol.43, pp.758-63, 2004.

M. Waldron, S. D. Patterson, J. Tallent, and O. Jeffries, The Effects of Oral Taurine on Resting Blood Pressure in Humans: a Meta-Analysis, Curr. Hypertens. Rep, vol.20, p.81, 2018.

J. Bartosiewicz, The activation of the kynurenine pathway in a rat model with renovascular hypertension, Exp. Biol. Med. (Maywood), vol.242, pp.750-761, 2017.

B. M. Nagy, Importance of kynurenine in pulmonary hypertension, Am. J. Physiol. Lung Cell. Mol. Physiol, vol.313, pp.741-751, 2017.

E. Strand, Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris, J. Am. Heart Assoc, vol.6, 2017.

T. J. Wang, 2-Aminoadipic acid is a biomarker for diabetes risk, J. Clin. Invest, vol.123, pp.4309-4326, 2013.

O. Zhenyukh, Branched-chain amino acids promote endothelial dysfunction through increased reactive oxygen species generation and inflammation, J. Cell. Mol. Med, vol.22, pp.4948-4962, 2018.

F. Teymoori, G. Asghari, P. Mirmiran, and F. Azizi, Dietary amino acids and incidence of hypertension: A principle component analysis approach, Sci. Rep, vol.7, p.16838, 2017.

U. Scherrer, D. Randin, P. Vollenweider, L. Vollenweider, and P. Nicod, Nitric oxide release accounts for insulin's vascular effects in humans, J. Clin. Invest, vol.94, pp.2511-2516, 1994.

M. R. Meyer, D. J. Clegg, E. R. Prossnitz, and M. Barton, Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors, Acta Physiol. (Oxf), vol.203, pp.259-69, 2011.

J. S. Kaufman, R. A. Durazo-arvizu, C. N. Rotimi, D. L. Mcgee, and R. S. Cooper, Obesity and hypertension prevalence in populations of African origin. The Investigators of the International Collaborative Study of Hypertension in Blacks, Epidemiology, vol.7, pp.398-405, 1996.